Lab Canary

1. What the Evaluator can see

The Evaluator will have access to the Example-1 model and its pre-release checkpoints, with and without safeguards; the internal safety documents listed in Schedule A; and the staff who wrote them. The Evaluator may request further information relevant to the Evaluation. Example Lab may refuse only where sharing would break the law or reveal customer or personal data, and will give written reasons for any refusal. The Evaluator may state publicly what access it had and where it considers that access insufficient.

2. What the Evaluator can publish

The Evaluator has final editorial control over its report. Example Lab may require redaction only of information in the categories listed in Schedule B, agreed before the Evaluation began: model weights and source code, unpatched security details, and customer or personal data. Example Lab may not require changes to the Evaluator's findings or conclusions. The Evaluator may state where and why material was redacted, and whether redactions affected its conclusions. The Evaluator may raise serious concerns directly with Example Lab's board or a relevant government authority.

3. Payment

Example Lab will pay the Evaluator a fixed fee of $400,000, worked out from the Evaluator's published day rates and set before the Evaluation begins. No part of the fee, or any future engagement, depends on the Evaluator's findings or conclusions.

4. How long it lasts

This agreement runs from 1 January 2027 to 31 December 2028. Example Lab may not end this agreement, or decline to renew it, because of the Evaluator's findings. Any decision not to renew will be published with its reasons.

5. This agreement is public

Example Lab publishes this agreement at examplelab.example/evaluations, with only Schedule B information redacted. Any change to it will be published within 30 days.

The fee, the dates and the reasons for refusing access are examples. A real lab and evaluator would set their own.

1. No stake in Example Lab

The Evaluator and its staff working on the Evaluation hold no equity or debt in Example Lab.

2. Not dependent on Example Lab

No more than 10% of the Evaluator's income in any year comes from Example Lab.

3. Other paid work

The Evaluator will not take other paid work from Example Lab during the Evaluation or for 12 months afterwards. It will disclose in its report any other paid work for Example Lab in the past two years.

4. Stepping aside

Any staff member with a close personal or financial tie to Example Lab will say so and step aside from the Evaluation.

The 10% and the 12 months are examples. A real lab and evaluator would set their own.

Scope of the Example-1 pre-release evaluation

The Evaluation covers Example Lab's claims that Example-1 gives no meaningful help to someone trying to make a biological or chemical weapon, and that its safeguards against this hold up under attack. It covers Example-1 and the two checkpoints tested before release. It does not cover cyber-attack risks, loss-of-control risks, or models used only inside Example Lab. Example Lab will publish this scope, including what was left out, alongside the Evaluator's report.

1. What counts as confidential

“Confidential Information” means non-public information such as model weights, source code, unreleased research, security details, and customer or personal data. It does not include your opinions, or information about Example Lab's conduct, safety practices, working conditions or possible wrongdoing, except where sharing it would also reveal Confidential Information as defined above.

2. Keeping it confidential

You agree not to share Confidential Information with anyone outside Example Lab, while you work here or afterwards, unless section 3 allows it or Example Lab agrees in writing.

3. What you can always do

Nothing in this agreement or any Example Lab policy stops you from reporting possible breaches of the law, or risks to public health or safety, to any government agency, regulator, legislator, law enforcement body or court; from speaking to a lawyer; or from receiving a reward for information given to a government agency. You don't need to tell Example Lab or ask its permission first. This applies even if the report has to include Confidential Information.

4. This agreement isn't secret

You may tell anyone that you have signed this agreement and what kind of agreement it is, and you may share its full text with your lawyer, financial adviser, immediate family or any government agency. No term of this agreement is itself confidential. Example Lab publishes the standard version at examplelab.example/terms.

In your employment contract

Nothing in this agreement stops you from making truthful statements about Example Lab, including criticism of its conduct, safety practices, ethics or compliance with the law. Example Lab does not ask anyone to agree to a non-disparagement term when they join or while they work here.

In a separation agreement, only if you choose

When you leave, Example Lab may offer you a separation agreement with a mutual non-disparagement term. Mutual means Example Lab makes the same promise about you. The term is optional, is given in return for benefits you would not otherwise receive, ends 24 months after you leave, and never applies to statements about safety, ethics, risks to the public or compliance with the law. You keep everything you have already earned whether or not you sign.

1. Your equity can't be used against you

Your vested equity and earned pay will not be forfeited, cancelled, bought back below fair market value, or excluded from any tender offer or sale because you raised a concern, criticised Example Lab or made a protected disclosure. Keeping your vested equity, or taking part in a tender offer or sale, never depends on signing a separation agreement.

2. The only reasons equity can be forfeited

Example Lab may only forfeit vested equity if you (a) sold or deliberately leaked Confidential Information, other than in a report the confidentiality agreement allows, or (b) committed fraud or theft against Example Lab. It must first give you its reasons in writing and a fair chance to respond.

These two reasons are examples. A real lab would list its own, and the list should stay this narrow.

1. Who can use it

Anyone who works or has worked for Example Lab: staff, contractors, interns and former staff.

2. What you can raise

Anything you believe is illegal, unsafe or unethical, or a risk to the public. That includes how models are trained, tested and released, and any gap between what Example Lab says publicly about safety and what it does.

3. How to raise it

You can raise concerns through the Speak-Up Line, which accepts anonymous reports. Reports go to the board's Safety and Audit Committee, which is independent of executive leadership. You can also talk to your manager, but you never have to.

4. You can always go outside

You never have to use this policy first. Nothing in it, or in your contract, stops you from reporting to a regulator, government body, law enforcement or a lawyer at any time.

5. No retaliation

Example Lab will not retaliate against anyone who raises a concern in good faith, and treats retaliation as serious misconduct. Retaliation includes dismissal, demotion, cuts to pay or equity, a bad reference and legal threats.

6. What happens next

The committee confirms it has your report within 7 days, looks into it, and tells you the outcome where it can.

7. Keeping it public

This full policy is published at examplelab.example/speak-up. Any change to it will be published within 30 days.

Statement for 1 January to 31 March 2027

Example Lab confirms that, on the date below:

1. Its standard employment, separation and equity terms and its speak-up policy are published at examplelab.example/terms.
2. Those terms meet all seven clauses of the Lab Canary standard.
3. No current or former member of staff is held to older terms that fall short of the published ones.
4. It has not enforced, or threatened to enforce, any agreement against anyone for raising a concern, criticising the company or making a protected disclosure.

Signed: General Counsel, Example Lab. Date: 1 January 2027. Next statement due: 1 April 2027. If no new statement is published by then, treat this one as expired.